Hepatitis C – Vanishing Disease? - Sammy Saab, MD, MPH | UCLA Digestive Diseases
Offered By: University of California, Los Angeles via YouTube
Course Description
Overview
Syllabus
Intro
Decreasing Prevalence of Chronic Hepatitis C Infection, NHANES 2003 to 2010
Increasing Number of Hospitalizations related to HCV in Los Angeles County, 2007-2009
Extrahepatic Manifestations of Chronic Hepatitis C
Evolution of Hepatitis C Therapy Genotype 1
Hepatitis C: Achieving a Cure
Properties of Direct Acting Agents
Combination of Direct Acting Agents
Disappearing Special Populations
Cure vs Relapse Great Balance Act
Special Considerations
Resistance Associated Variants (RAV) General Principles
Resistance Testing
Treatment Regiments for Genotype 1 Patients
Treatment of non-Genotype 1 Patients
Grazoprevir and Elbasvir in Patients with Stage 4 or 5 Chronic Kidney Disease
Recommended Monitoring for patients after Antiviral Treatment
Improving the HCV Test and Cure Continuum: High Drug Costs are Not the Only Barrier
Model-Based Predictions The Changing Burden of Hepatitis C Virus Infection
Changes in CPT and MELD Scores from Baseline.
Taught by
UCLA Health
Tags
Related Courses
Know HBV And HCV - - - - Hiểu Rõ Về Viêm Gan B Và C (English & Vietnamese)Stanford University via Stanford OpenEdx Viral Hepatitis
Institut Pasteur via France Université Numerique Prekausaun padraun: Seguransa injesaun no jestaun kanek sona ho daun
OpenWHO ON DEMAND WEBINAR SERIES: Annual Clinical Intersection of HIV/AIDS: A Practical Discussion of Connecticut's Course Mandates
Yale University via Independent Blood - The Liquid Tissue Transplant - EM & Acute Care Course
The Center for Medical Education via YouTube